You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zanubrutinib

Showing 76 - 100 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Relapsed or Refractory Small Lymphocytic Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +15 more
Sep 29, 2021

B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

Completed
Has Results
  • B-cell Lymphoid Malignancies
  • Fort Myers, Florida
  • +14 more
Mar 1, 2022

Mature B-cell Malignancies Trial in Japan (Zanubrutinib)

Recruiting
  • Mature B-cell Malignancies
  • Zanubrutinib
  • Nagoya, Aichi, Japan
  • +14 more
Feb 18, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

Completed
Has Results
  • Marginal Zone Lymphoma
  • +2 more
  • Harbin, Heilongjiang, China
  • +3 more
Oct 26, 2021

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
Has Results
  • Waldenström's Macroglobulinemia (WM)
  • Zanubrutinib
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

Refractory Mantle Cell Lymphoma, Relapsed Mantle Cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Refractory Mantle Cell Lymphoma
  • Relapsed Mantle Cell Lymphoma
  • Zanubrutinib
  • Beijing, Beijing, China
  • +13 more
Oct 8, 2021

Waldenström Macroglobulinemia Trial in Tianjin (Zanubrutinib,Ixazomib and Dexamethasone)

Recruiting
  • Waldenström Macroglobulinemia
  • Zanubrutinib,Ixazomib and Dexamethasone
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 8, 2020

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Zanubrutinib
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 5, 2021

Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

Recruiting
  • Mature B-Cell Malignancies
  • Stanford, California
  • +26 more
Dec 16, 2021

r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

Not yet recruiting
  • B-cell Lymphoma
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Aug 9, 2022

Healthy Volunteers Trial in Secaucus (BGB-3111, Placebo, Moxifloxacin)

Completed
  • Healthy Volunteers
  • Secaucus, New Jersey
    Frontage Clinical Services, Inc.
Apr 22, 2020

Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))

Not yet recruiting
  • Atrial Fibrillation
  • Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
  • Caen, Normandie, France
    Caen University Hospital, Department of Pharmacology
Sep 6, 2023

Hepatic Insufficiency & Healthy Subjects Trial in Miami, Orlando (Zanubrutinib)

Completed
  • Hepatic Insufficiency & Healthy Subjects
  • Zanubrutinib
  • Miami, Florida
  • +1 more
Apr 22, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Little Rock, Arkansas
  • +144 more
Dec 3, 2021

Primary Vitreoretinal Lymphoma Trial in Beijing (Intravitreal injection of methotrexate)

Recruiting
  • Primary Vitreoretinal Lymphoma
  • Intravitreal injection of methotrexate
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 11, 2023

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic

Recruiting
  • Atrial Fibrillation
  • +4 more
  • Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
  • New Hyde Park, New York
    Northwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Healthy Subjects Trial in Daytona Beach (BGB-3111 and Drug Cocktail)

Completed
  • Healthy Subjects
  • BGB-3111 and Drug Cocktail
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Nov 1, 2019

Newly Diagnosed Mantle Cell Lymphoma Trial in Zhengzhou (Rituximab)

Recruiting
  • Newly Diagnosed Mantle Cell Lymphoma
  • Zhengzhou, Henan, China
    Department of Oncology, The First Affiliated Hospital of Zhengzh
Aug 17, 2022

Relapsed/Refractory Follicular Non-Hodgkin Lymphoma Trial in Worldwide (Zanubrutinib, Obinutuzumab)

Active, not recruiting
  • Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
  • Atlanta, Georgia
  • +119 more
Feb 23, 2022

Healthy Volunteers Trial in Adelaide (Zanubrutinib)

Completed
  • Healthy Volunteers
  • Zanubrutinib
  • Adelaide, South Australia, Australia
    CMAX
Nov 12, 2019

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
Oct 13, 2021